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Su lnmal 'y  
A novel Hodgkin cell line, designated HD-MyZ, was established from the pleural effusion of 
a 29-yr-old patient with Hodgkin's disease (HD) of nodular sclerosing type. The majority of 
cells grow adherently and display typical morphological characteristics of Reed-Steruberg (RS) 
and Hodgkin (H) cells, i.e., large multi- and mononucleated cells with prominent nucleoli. 
Immunofluorescence analysis revealed a myelomonocytoid immunophenotype (expression fCD13 
and CD68, and lack of lymphoid markers). HD-MyZ cells strongly expressed restin, a recently 
described intermediate filament-associated protein, the expression of which is restricted to H 
cells, RS cells, and in vitro cultivated peripheral blood monocytes. Inaddition mRNA expression 
of c-f ms (colony-stimulating factor 1 receptor) could be induced in HD-MyZ cells by phorbol 
myristate acetate (PMA) stimulation. Southern blot analysis did not detect rearrangement of 
T cell receptor j8 and immunoglobulin H loci, thus demonstrating the lack of lymphoid 
commitment. HD-MyZ cells were also devoid of Epstein-Barr virus genomes. HD-MyZ cells 
constitutively express mRNAs for interleukin lo~ (IL-lc~), IL-1/~, IL-5, IL-6, IL-7, IL-8, IL-10, 
IL-1 receptor (type I), and IL-6 receptor. Stimulation of cells with PMA increased mRNA expression 
as well as the secretion of IL-I~/, IL-6, and IL-8, and induced the de novo expression of IL-8 
receptors. Xenotransplantation into severe combined immunodeficient (SCID) mice by intravenous 
or subcutaneous inoculation led to development of disseminated tumors with infiltrative and 
destructive growth. In addition lymphadenopathy, pleural effusion, and infiltration of spleen 
were observed. Morphological nd immunological nalysis of tumor cells revealed the same features 
as HD-MyZ cells. This cell line might be an important tool for understanding the pathogenesis 
and biology of HD. In addition the SCID mice model might prove helpful in developing new 
therapeutic strategies. 
H odgkin's disease (HD) 1 is characterized bythe presence of typical malignant cells (multinucleated Reed-Stern- 
berg [RS] and mononucleated Hodgkin [H] cells) amid a back- 
ground of reactive lymphocytes, plasma cells, histiocytes, neu- 
trophils, eosinophils, and stromal cells (1). The cell of origin 
of HD still remains controversial (2). The establishment of
several HD-derived cell lines recently (3) enabled a more 
I Abbreviations u ed in this paper: HD, Hodgkin's disease; RS, Reed- 
Sternberg; RT, reverse transcription. 
detailed analysis of the cellular origin as well as the biology 
of these tumor cells. These efforts, however, have been ham- 
pered by the fact that H or RS cells usually account only 
for a minority of cells within the cellular background inHD 
tissue. Most of the cell lines were derived from pleural effusions 
containing RS or H cells. Various hematopoietic cells, in- 
cluding lymphocytes, monocytes, and interdigitating retic- 
ulum cells, have been speculated to be the normal counter- 
part of RS and H cells (2, 4-10). The majority of tumor 
cell lines, however, derived from HD that have been described 
so far were found to be related to lymphocytes (2, 4-7). 
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The histopathological as well as a number of clinical fea- 
tures of HD might reflect the unbalanced production of 
cytokines, e.g., B symptoms (night sweats, fever, weight loss), 
eosinophilia, cute phase reaction proteins, and thrombocy- 
toffs. Subsequently the expression of various cytokines has 
been studied in HD-derived tumor cell lines (11). 
In this report we describe the morphologic, immunopheno- 
typic, molecular genetic, and functional characterization f 
a novel HD-derived cell line (HD-MyZ) consisting of typical 
KS and H cells, which display myelomonocytoid characteris- 
tics. An in vivo model of HD could be established by xeno- 
transplantation f HD-MyZ cells into SCID mice. 
Materials and Methods 
Case History. H and lLS cells were isolated from a pleural effusion 
of a 29-yr-old patient with HD refractory to multiple therapy 
regimen. In 1980 HD of nodular sclerosing type (stage Ilia) was 
diagnosed in patient MZ. Initial treatment consisted ofcombined 
chemo- and radiotherapy. The patient relapsed several times with 
disseminated manifestations, i cluding abdominal, cervical, and ax- 
illary lymph nodes, right proximal humerus, and right iliac crest. 
In September 1991 tumor progression could be observed with evo- 
lution of pleural effusion, infiltration of psoas muscle, and mul- 
tifocal bone marrow infiltration despite intensive chemotherapy. 
In addition the patient complained offevers unresponsive to anti- 
biotics and antifungal therapy. The patient's general condition de- 
teriorated rapidly and the patient died in November 1991. Due to 
the fact that a high number of H and lLS cells could be seen within 
the smear cytology of the pleural fluid, this was the first patient 
with HD from whom we made an attempt to derive a cell line. 
Culture Conditions and Reagents. Cell population of the pleural 
fluid consisted predominantly of large mono- and multinuclear cells 
with morphological features ofH and RS cells. After Ficoll-Hypaque 
separation cells were transferred into culture and maintained in
I~PMI 1640 (Seromed-Biochrom, Hamburg, Germany), 20% heat- 
inactivated FCS, 2 mM L-glutamine (Gibco, Karlsruhe, Germany), 
and penicillin-streptomycin (Seromed-Biochrom). Where indicated, 
cells were cultured in the presence ofPMA (10 ng/ml; Sigma Chem- 
ical Co., Miinchen, Germany) or LPS (Sigma Chemical Co.). 
Human PBL were cultured in RPMI plus 5% FCS in the presence 
of 5 ng/ml PMA plus 0.1% PHA for 24 h. Thereafter, cells were 
harvested for lLNA extraction. The Burkitt lymphoma cell lines 
BJAB, Raji, and BL60 and the T cell lymphoma call line Jurkat 
were used as controls in various experiments. 
Analysis of Antigen Expression by Immunofluorescence. C lls were 
analyzed after staining with various mAbs. The antibodies were 
obtained from the panel of the Fourth International Workshop on 
Leucocyte Differentiation A tigens or purchased from Becton Dick- 
inson & Co. (Heidelberg, Germany) and Coulter (Krefeld, Ger- 
many). TNF receptor mAbs utr-1 (type II receptor) and htr-9 (type 
I receptor) were kindly provided by Dr. Manfred Brockhaus 
(Hoffmann-IaRoche, Basel, Switzerland). mAb anti-APO-1 (IgG3) 
was a generous gift from Dr. Peter Krammer (German Cancer Re- 
search Center, Heidelberg, Germany). Cells (106) were incubated 
with 5 ~tg/ml mAb in PBS (Containing 0.1% NaN3 and 10% 
human IgG; Venimmun Behring, Marburg, Germany). After 
washing, cells were incubated with Biotin (Fab)2 goat anti-mouse 
IgG (Dianova, Hamburg, Germany) for 30 rain at 4~ Thereafter 
cells were incubated with Streptavidin-FITC (Dianova), washed, 
and fixed with 1% formalin. Indirect immunofluorescence was mea- 
sured using a FACScan | flow cytometer (Becton Dickinson & Co.). 
Human tumor cells were detected inSCID mice by staining with 
an anti-human HLA-DIL mAb (B8.12.2; Dianova), which does 
not crossreact with mouse cells. Double staining of human tumor 
cells from SCID mice was performed using a PE-labeled anti-HLA- 
DR mAb (Dianova) and FITC-labeled CD13, CD19, CD71, and 
CD25 mAbs (Becton Dickinson & Co.). 
Cytoplasmic antigens were detected as described using cytocen- 
trifuge preparations (12). Cells were fixed with paraformaldehyde 
and treated with Triton X-100 (0.5%). After incubation with mAb, 
cells were stained with FITC-labeled goat anti-mouse IgG 
(Dianova). 
Xenotransplantation of Tumor Cells into SCID Mice. HD-MyZ 
cells (10 6 ) were injected either subcutaneously or intravenously into 
C.B.-17 scid/scid mice (13). The mice were obtained from our own 
breeding colony and were kept in isolators under stringent condi- 
tions in the Central Animal Laboratory, German Cancer Research 
Center. Microbiological controls were performed regularly by ad- 
dition of sterile sentinel animals to the colony. 
Detection of Cytokines by ELISA. Secretion of Ibl/~, IL-6, and 
Ib8 into the supernatant of HD-MyZ was measured byQuantikine 
assays (Biermann, Bad Nauheim, Germany) according to the 
manufacturer's manual. 
Detection ofmRNA by PCR. Total RNA was extracted from 
viable calls as described by Gough (14). Purification of poly(A +) 
RNA from 10/~g of total RNA was performed using the Dy- 
nabead mlLNA Purification Kit (Dynal, Oslo, Norway). Detec- 
tion of mlLNA by PCIL was performed as described by Wang et 
al. (15) using a Geneamp RNA PCR Kit (Perkin Elmer-Cetus, 
Ubedingen, Germany) and a thermocyder (Bachhofer, Reutlingen, 
Germany) according to the PCIL kit protocol. In detail, 1/~1 of 
the eluted poly(A +) mlLNA (total volume, 20/~1) was used for 
reverse transcription (ILT) with a sequence-specific downstream 
primer directly followed by a PCR amplification step using an up- 
stream primer. To rule out false-positive results due to DNA con- 
tamination, we always ran negative controls without RT. One- 
third of the PCIL volume was run on an agarose gd (1%). After 
transfer to a nylon membrane and UV crosslinking, filters were 
prehybridized in hybridization buffer (50%, vol/vol, formaldehyde, 
6• SSC, 0.1% SDS) for 4 h at 55~ cDNA was hybridized with 
a 32p-labeled internal oligonucleotide complementary to asequence 
between the upstream and downstream primers. Probes were la- 
beled using a Y-oligonucleotide end-labding kit (British Biotech- 
nology, Oxford, UK). Filters were hybridized for 16 h at 55~ 
Filters were then washed twice for 30 rain with 6x SSC, 0.1% 
SDS at 70~ Table 1 shows oligonucleotide s quences u ed for 
RT-PCR and hybridization aswell as length of the expected PCP, 
products (16-47). 
Southern Blotting and Hybridization Probes. Total cellular DNA 
was extracted and digested with restriction endonucleases using 
standard protocols (48). 10/~g of digested DNA was electropho- 
retically separated in 1% agarose gels and transferred to nylon mem- 
branes (Genescreen Plus; DuPont Co., Wilmington, DE). Hybrid- 
ization probes labeled with 32p using the oligo-primed labeling 
method (49) were used in 50% formamide, 2x SSC at 42~ (Tin, 
-20~ Control DNA was extracted from placenta, the human 
Burkitt lymphoma lines BJAB, Namalwa, and BL60, as well as 
the T lymphoma cell line Jurkat. 
To analyze the human Ig heavy chain gene and the TCtL-~ gene 
for rearrangements, a genomic 2.2-kb Sau3a fragment of the joining 
region (IgHj region) (50) and an 800-bp cDNA sequence 0UIL- 
b2) (51) were used, respectively. For the detection of EBV DNA 
the Bgl2 U fragment (nucleotides 13944-17016) (52) specific for 
the EBV internal repeat 1 (IlL 1) was used. 
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Table 1. Oligonucleotide S quences 
mRNA bp 5'-3' Sequence 3'-5' Sequence Internal oligonucleotide 
/~-actin(16) 246 GAGCTGCGTGTGGCTCCCGAGG 
IL-1/~(17) 610 CCTCCAGGGACAGGATATGGAGC 
IL-2(18) 458 ATGTACAGGATGCAACTCCTGTCTT 
IL-2R(Tac)(19) 502 CCCTTGGCTCAATCCTCTAAG 
IL-3(20) 449 ATGAGCCGCCTGCCCGTCCTG 
IL-4(21) 408 CCTCCCAACTGCTTCCCCC 
IL-4R(22) 472 TCTTCCACCTTCGGGAAGTACG 
IL-5(23) 368 CCCCACAGAAATTCCCACAAG 
IL-6(24) 595 GGATTCAATGAGGAGACTTGCC 
IL-6R(p80)(25) 251 CATTGCCATTGTTCTGAGGTTC 
IL-7(26) 402 CATGGTCAAAACGGATTAGGG 
IL-7R(27) 605 GCCCTCGTGGAGGTAAAGTGCC 
IL-8(28) 308 GGACAAGAGCCAGGAAGAAACC 
IL-SR(29) 440 GGGGGACGCTATAGGATGTGGG 
IL-10(30) 467 CCCTGACCTCCCTCTAATTTATC 
GM-CSF(31) 424 ATGTGGCTGCAGAGCCTGCTGC 
TNF-c~(32) 450 GACAAGCCTGTACGGCATGTTG 
TNF-/~(33) 421 CCTCAAACCTGCTGCTCACCTC 
TNF-R.I(34) 601 GTGGAAGTCCAAGCTCTACTCC 
TNF-RII(35) 468 CTGCCGATAAGGCCCGGGGTAC 
c-rayc(36) 564 CCGCCCGCGGCCACAGCGTCTG 
c-myb(37) 610 GCCTCCTTTAACTTCCACCCCC 
c-fgr(38) 520 GGCGGTGAAGACGCTGAAGCCG 
N-ras(39) 464 CCCACCATAGAGGATTCTTAC 
bc1-1(40) 444 CGGGAAAGGCCACCTGTCCCAC 
bci-2(41) 441 GGTGCCACCTGTGGTCCACCTG 
p53(42) 576 GGCCCCTGTCATCTTCTGTCCC 
TGF-/~(43) 530 GCGCCCACTGCTCCTGTGACAGC 
restin(44) 420 GGCAGCTCAGCAGCTCCTCAGGT 
IL~1,v(17) 308 GTCTCTGAATCAGAAATCCTTCTATC 
IL-1R, I(45) 548 GGTACAGGGATTCCTGCTATG 
c-kit(46) 452 CGGGAAGCCCTCATGTCTGAAC 
c-f ms(47) 491 CCATGGATGGGGCGACACGGGG 
CGCAGGATGGCATGGGGGAGGGCATACCCC 
GGCTCAATAAAAGGGCTGGGG 
GTCAGTGTTGAGATGATGCTTTGAC 
CTGGGGAGCTGGGGTTATAGGC 
GCGAGGCTCAAAGTCGTCTGTTG 
GCCTTTCCAAGAAGTTTTTCC 
GGCCTGGGTGCCACCCTGCTCC 
GGCCTGACTCTTTCTTGGCCC 
CAAACTGCATAGCCACTTTCC 
AGTAGTCTGTATTGCTGATGTC 
CTCTCTTATTCTCACCGGC 
GGGAGACTGGGCCATACGATAG 
CTTCAAAAACTTCTCCACAAC 
CACAAGGCCAGTTGGCAGGTTG 
CAGGCTGGAGTACAGGGGCAC 
CTGGCTCCCAGCAGTCAAAGGG 
GGGCAATGATCCCAAAGTAGAC 
AGTTCTACAGAGCGAAGGCTCC 
CGATGTCCTCCAGGCAGCCCAG 
GCTTCATCCCAGCATCAGGCAC 
CCTCGGTGTCCGAGGACCTGGG 
CTGCTCCTCCATCTTTCCACAG 
GCCTGGGTAGGGGATTCGGCCC 
GGTAATCCCATACAACCCTGAG 
CATCCTGGCAATGTGAGAATGC 
GTTCACTTGTGGCCCAGATAGG 
GCCGGTCTCTCCCAGGACAGGC 
GGCGGGGCGGGGCGGGGCGGG 
AAGGTTTCGTCGTCATTGCAGTTGG 
CATGTCAAATTTCACTGCTTCATCC 
GGTGACCGTCGCTGGACTGGC 
GCGAGGAAAGCCATGCCCTTTG 
GGAGTGAAGGCGGCGTATAGGG 
GCCAGTGGTAGCGCCAGAGGCGTACAGGG 
GGAGAGAGCTGACTGTCCTGGCTGATGGAC 
CTTCTTCTAGACACTGAAGATGTTTCAGTTC 
CTCTTAAAGAGGCCAATTAGTAACGCACAG 
GCCTCCAGGTTTGGCCTTCGAAGGTTATTTTC 
CCGTTTCAGGAATCGGATCAGCTGCTTGTG 
GGACATTTCGGCGGAGGATCTGTCCCCAGG 
CCCCCTTGCACAGTTTGACTCTCCAGTGTG 
GTGTCCTAACGCTCATACTTTTAGTTCTCC 
CATCTGGTCGGTTGTGGCTC 
CTCTAAAACATCTCCAGCACAGAAGAAGAC 
GCTGATGGTTAGTAAGATAGGATCCATCTCC 
GTTCTTTAGCACTCCTTGGCAAAACTGCAC 
CACCTGAGATGGGAAAACCACCCCCCTGAG 
GTGCTGGGACTACAGGCGTGAGCCACCGCG 
GCTGGCCATCATGGTCAAGGGGCCCTTGAGC 
GGGCCGATTGATCTCAGCGCTGAGTCGGTC 
AGGGCTGAGGACTAGGTGGGGGATGCCATC 
GCTTGAAGGAACTACTACTAAGCCCCTGG 
GCTCCAGCAGCAGCTCCCTGGAGAGCTCG 
GCAGGATAGTCCTTCCGAGTGGAGGGAGGC 
CTGCTACAAGGCTGCAAGGGGCTCGCCAGG 
GAGCTCAGTGAGCAGGATCCCAAAGGACC 
CTTCAACACCCTGTCTGGTCTTGGCTGAGG 
GGCACGCAGCCTCCCAAACACCCCACCTCC 
AGGGCGTCAGGTGCAGCTGCCTGGACATC 
CCTCAAAGCTGTTCCGTCCCAGTAGATTAC 
GGGGCAGGGCCCGAGGCAGAAGTTGGCATG 
GGGCGTTCCTCACCCCGACTGCCATGGTG 
GATTGATGCATGGACCCTTGATGGAGTGGGCC 
CATGGCTATTTGCTCTTCAGATGAACCACC 
GGCCAACTCGTCATCCTCCATGATGGCGGG 
CCTGCTCCAAGGGGCCTGAGCTGAGTGTGG 
Results 
Cell Culture and Cytology. Mono- and muhinuclear cells 
with characteristics of H and RS cells were isolated from the 
pleural fluid by Ficoll-Hypaque separation and were trans- 
ferred into culture medium as described. The majority of the 
cells grew adherently. Large muhinucleated RS-like cells (as 
shown in Fig. 1 a) account for •10% of the cell population 
at a stable frequency. Ceils were grown at a concentration 
of 10 ~ cells/ml, and culture medium was replaced every 
other day. 
Ceils have been in continuous culture without morpho- 
logical and phenotypical changes since November 1991. Cyto- 
logic appearances of the cell line HD-MyZ demonstrating 
the typical morphological features of RS and H cells are shown 
in Fig. 1 a. Fig. 1, b and c, show hematoxyline/eosin taining 
of patient's bone marrow sections with infiltration by H and 
RS cells. 
HD-MyZ Cells Display Myelomonoq/toid Features. Pheno- 
typic analysis of the cell line was performed by immunofluores- 
cence using a flow cytometer and cytocentrifugation (Table 
2). RT-PCR was used for analysis of mRNA expression. Cells 
strongly expressed CD13 (MyT), MHC class II (HLA-DR), 
and CD68, but did not express either B or T cell lineage-as- 
sociated antigens, thus indicating myelomonocytoid differen- 
tiation. 
Cells were also positive for MHC class I, transfetfin receptor 
(CD71), CD10, and CD29 (integrin 81 chain). The activa- 
tion antigen CD30 (Ki-1), which is strongly expressed on 
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Figure 1. Morphology of HD-MyZ cells: (a) 
Cytospin preparations. HD-MyZ cells (mono- and 
multinucleated cells) were stained with hematox- 
ylin/eosin (x 63). (b and c) Bone marrow sections 
from patient MZ were stained with hematoxylin/ 
eosin. Infiltration fthe patient's bone marrow by 
H and RS cells (x 100). 
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Table 2. Immunopkenotype of HD-MyZ Cell Line 
B cell lineage T cell lineage Myeloid lineage 
CD antigen Expression CD antigen Expression CD antigen Expression 
Other 
CD antigen Expression 
CDI9(HD37) 
CD20(IF5) 
CD21(HB5) 
CD37(HD28) 
CD22(HD39) 
CD23(HD50) 
CD38(T10) 
CD39(AC-2) 
CD40(G28-5) 
CD76(HD66) 
CD77(BLA-1) 
IgG 
IgD 
IgM 
CDla(T6) 
CD2(T11) 
CD3(Leu-4) 
CD4(Leu-3) 
CD7(Leu-9) 
CD8(Leu-2) 
CDS(Leu-10) 
B 
m 
CD13(My7) + + + 
CD14(Mo2) 
CDltb(Mol) 
CDa3(My9) 
CD34(My10) 
CD15(L16) 
CD68(cytopl) + + 
TNF-RI(utr-1) 
TNF-RII(htr-9) 
CD25(TAC) 
CD10(J5) + + 
CD56(L19) 
CD71 + 
CD29(4B4) + + + 
MHC II(HLA-DR) + + + 
MHC I(W6/32) + + 
CD30(Ki-1) 
APO-I/Fas 
HEA-125 
H and RS cells in most cases of HD, could not be detected 
on the cell surface. A weak cytoplasmic staining, however, 
was repeatedly observed. 
Recently, anovel intermediate filament-associated protein, 
designated restin, has been described, which is found to be 
expressed in in vitro cultured human peripheral blood mono- 
cytes. This novel marker appears to be abundantly expressed 
in RS cells (44). Using RT-PCR analysis we were able to 
detect restin mRNA expression i  HD-MyZ cells (Fig. 2). 
Germ Line Configuration fthe IgH and the TCR-~ Loci in 
HD-MyZ. Since HD-MyZ cells were lacking cell surface 
markers of lymphoid ifferentiation but revealed instead my- 
elomonocytoid features (coexpression f CD13, HLA-DR, 
CD68, and restin), we were interested in further studying 
lymphoid commitment on a molecular genetic level. Using 
BamHI- or EcoRI-digested DNA from HD-MyZ cells no 
rearranged bands were detected with IgJ, region of TCR/$ 
probes (Fig. 3). 
Absence of EBV Genomes inHD-MyZ. No EBV-specific 
sequences were detected in HD-MyZ (H) as well as the EBV- 
negative cell lines BJAB (B) and Jurkat (J). In the human 
Burkitt's lymphoma line Namalwa(N), which carries two 
integrated copies of the EBV genome (51), the 3.1-kb BamHI 
fragment (W) is clearly detected (Fig. 4). 
mRNA Expression of Oncogenes, Cytokines, and Cytokine 
Receptors. We studied the mRNA expression of a number 
of well-characterized proto-oncogenes and suppressor genes. 
As shown in Fig. 5 a, specific transcripts of p53, c-myc, and 
bob1 could be detected. In addition expression of N-ras and 
c-myb was also detected, whereas mRNA expression of bcl-2 
and c-fgr oncogenes was not observed. Expression of the proto- 
oncogene c-f ms (CSF-1 receptor) could be observed after PMA 
stimulation for 8 h (Fig. 6 b). Table 3 summarizes the expres- 
sion of these genes in HD-MyZ cells. 
Since part of the clinical symptoms and of the pathology 
of HD might be explained by the unbalanced production of 
tumor cell-derived cytokines, we were interested in studying 
the constitutive mRNA expression of cytokines and their 
receptors. HD-MyZ cells were found to constitutively ex- 
press transcripts of IL-lc~, IL-1/$, IL-5, IL-6, IL-7, IL-8, IL- 
10, as well as IL-1 (type 1) receptors (Fig. 5 b). In contrast, 
the cells did not express TNF-~ IL-3, or GM-CSF (Fig. 5 c). 
Table 3 summarizes the data on cytokines and cytokine 
receptors. 
In addition, we studied the regulation of cytokine and 
cytokine receptor expression after in vitro stimulation with 
phorbol esters. In vitro stimulation with PMA for 24 h in- 
duced the de novo expression of IL-SR mRNA (Fig. 6 a). 
Secretion of Cytokines. We assessed the secretion of IL- 
I/$, IL-6, and IL-8 into the cell-free supernatant of our cell 
line by ELISA. In accordance with our mRNA expression 
data, high levels of IL-8 and moderate l vels of IL-6 and IL- 
1/$ could be detected in the supernatant ofunstimulated HD- 
MyZ cells. Stimulation with PMA for 40 h led to a marked 
increase in IL-6, IL-8, and IL-13 secretion (Table 4). 
Xenotransplantation into SCID Mice. 106 cells were in- 
Figure 2. Restin expression in HD-MyZ. Au- 
toradiographs of blotted and hybridized RT-PCR 
products. Constitutive r stin mRNA expression 
is observed in HD-MyZ cells (lane 1), whereas 
freshly isolated human PBL did not express restin 
mRNA (lane 2). B-actin expression in both cell 
lines was used as control. 
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Figure 4. Absence of EBV ge- 
nomes in HD-MyZ. A Southern blot 
of BamHI-digested DNA was pre- 
pared as described in Fig. 3 and was 
hybridized with a probe specific for 
the EBV internal repeat 1 (EBV IR1). 
No EBV-specific sequences were de- 
tected in HD-MyZ (/-/) as well as the 
EBV-negative cell lines BJAB (B) and 
Jurkat 0). In the human Burkitt's 
lymphoma line Namalwa (N), which 
carries two integrated copies of the 
EBV genome (53), the 3.1-kb BamHl 
W fragment (W) is clearly detected. 
Figure 3. Germline configuration of the IgH and the TCR-B loci in 
HD-MyZ. Approximately 10/~g of cellular DNA was digested with BamHI 
and EcoRl restriction endonucleases, respectively, separated by electropho- 
resis in 1% agarose gds, transferred on nylon membranes, and hybridized 
with a 32P-labeled IgH J region-specific DNA probe and autoradiographed 
(top). After removal of the IgH J probe the same blot was rehybridized 
with a cDNA probe specific for the TCR fl gene (bottom). The IgH ] 
region probe detected germ line fragments of 16 kb (BamHI) and 13 kb 
(EcoRI) in HD-MyZ (/4) as well as in human placenta DNA (P) and the 
human T cell line Jurkat (I). In control DNA from B lymphoma lines 
BJAB (B)-, Namalwa (N)-, and BL60 (B/), rearranged fragments were 
present. The TCIk B gene probe detected germ line fragments of'~20 kb 
(BamHl) and 11, 4, and 3.5 kb (EcoR1) in HD-MyZ (H) as well as in 
all control call lines, except for the T cell line Jurkat (/'), which contains 
an additional rearranged 9-kb EcoRI fragment. 
jected either intravenously or subcutaneously into SCID mice. 
Animals from both groups developed fatal disease within 5 
wk after injection. At autopsy massive tumors were observed 
at the site of injection (subcutaneous group). In addition, 
infiltration and enlargement of axillary, inguinal, and retro- 
peritoneal lymph nodes and spleen as well as pleural effusion 
were noticed. In contrast o subcutaneous application, intra- 
venous injection led to a more prominent infiltration of the 
visceral organs, a massive pleural effusion, and psoas muscle 
infiltration. Primary tumor tissue consisted of large KS- and 
H-like cells. The spleen was found to be infiltrated by tumor 
cells (Fig. 7, a and b). 
For detection of human cells within single call suspensions 
of tumor cells obtained from the primary tumor (subcuta- 
neous group), metastatic lymph nodes, spleen, and pleura1 
effusion by flow cytometry (FCM) analysis, a PE-labeled anti- 
human HLA-DR antibody was used that does not crossreact 
with mouse calls. HLA-DR + cells were gated. FCM anal- 
ysis of these SCID mice-derived tumor cells with double 
immunofluorescence was performed using PE-labeled anti- 
human HLA-DR and FITC-labded CD13, CD19, CD25, 
Figure 5. mKNA expression of cytokines, cytokine receptors, and proto-oncogenes in HD-MyZ cells. (a) RT-PCR products were blotted, autoradio- 
graphed, and hybridized as described above. Specific transcripts for c-myc, p53, and kl-1 were detected in unstiraulated I--ID-MyZ cells. (b and c) Autora- 
diographs of blotted and hybridized KT-PCK products are depicted. (b) Specific transcripts for IL-lfl, IL-1 receptor(type 1), IL-5, IL-6, Ib7, and IL.8 
were observed, whereas mRNA products of TNF-c~, IL-3, and GM-CSF could not be detected in HD-MyZ cells (lanes 1, 3 and 5). Raji cells (lanes 
2 and 6), PHA plus PMA-stimulated human PBL (lane 4), as well as B-actin ~pression were used as controls (c). 
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Figure 6. Expression flL-8 receptor and proto-oncogene c-fras (CSF- 
1 receptor) is induced in HD-MyZ by PMA treatment. (a) HD-MyZ calls 
were in vitro activated with 10 ng/ml PMA for 24 h (lane 2). Control 
cells were cultured for the same period in culture medium alone (hne 1). 
In control calls no IL-8 receptor mRNA expression could be detected. In 
contrast, significant amounts of IL-8 receptor transcripts were observable 
after 24 h of PMA stimulation, fl-actin expression served as control. (b) 
HD-MyZ cells were stimulated with 10 ng/ml PMA. Unstimulated cells 
did not reveal c-f ms expression (lane I), whereas c-fins transcripts could 
be detected after 8 h of PMA stimulation. 
and CD71, and revealed a phenotype corresponding to that 
of HD-MyZ cells (Fig. 8). Cells from all these tumor sites 
were transferred into culture medium and showed the same 
growth characteristics. 
Discussion 
The pathogenesis of l id  and, at its center, the cdlular origin 
of the H or P,S cells still remain enigmatic. Almost every 
hematopoietic cell, including both B and T lymphocytes, 
monocytes/macrophages, myeloid cells, and interdigitating 
reticulum cells, has been speculated to be the normal coun- 
terpart (for review see reference 2). With the advent of sev- 
eral HD-derived tumor cell lines it has been possible to carry 
out detailed studies on the biology and the origin of these 
cells. Due to the fact that H or RS cells account only for 
a minority of cells within the bystander cells in HD tissue 
and that many attempts to cultivate H or RS cells failed, one 
has to bear in mind that those cell lines, which were success- 
fully derived from HD, might only reflect a certain aspect 
of the disease. Thus, one has to be careful in drawing gener- 
alizations from these cell lines about he in vivo biology and 
origin of H or RS calls. 
We describe the successful establishment of a novel H cell 
line, which was derived from the pleural fluid of a patient 
with HD of nodular sderosing type. The morphological nal- 
ysis of the cells within the pleural effusion disclosed the typ- 
ical features of RS and H cells, i.e., large multinucleated and 
mononucleated cells with prominent nudeoli. These cells were 
transferred into culture medium, grew adherently, and have 
been in continuous culture since November 1991. The im- 
munophenotyping disclosed that the HD-MyZ cell line was 
devoid of B or T lineage-associated markers (Table 2). HD- 
MyZ cells were found to strongly express CD13, a cell sur- 
face antigen expressed on myelomonocytic cells. MHC HLA- 
DR, CD71, CD10, and cytoplasmic CD68 were also detected. 
This phenotype (CD13 +, CD68 + , HLA-DR +) is compat- 
ible with myelomonocytic differentiation (54, 55). Repeated 
FCM analysis did not show any change in cell surface an- 
tigen expression. CD13 (identical to aminopeptidase-N) and 
Table 3. Constitutive raRNA Expression of Selected Cytokines, 
Cytokine Receptors, and Proto-oncogenes 
mRNA expression HD-MyZ 
IL-la + 
IL-1B + 
IL-2 
IL-3 
IL-4 
IL-5 + 
IL -6 + 
IL-7 + 
IL-8 + 
IL-10 + 
GM-CSF 
TGF-fl 
TNF-a 
TNF-3 
IL-1R(type 1) + 
IL-2R(CD25) 
IL-3R(c~-chain) 
IL-4R 
IL-6R (p80) + 
IL-7R 
IL-8R" + 
TNF-R (type I) 
TNF-R(type II) 
c-m F + 
c-myb + 
bcl-1 + 
bd-2 
c-k/t 
N-ras + 
p53 + 
c-f~t" 
c - f  ms * + 
* Induction after PMA stimulation. 
CD10 (identical to neutral endopeptidase) are both metal- 
loproteases. Both proteases are thought o be involved in the 
inactivation of regulatory peptides at the cell surface (56). 
CD30 expression was not observed on the cell surface of 
HD-MyZ cells. Interestingly, another HD-derived cell line 
(SU/KH-HD-1) displaying myelomonocytic features, i.e., 
CD14 expression, was also described to be devoid of the HD- 
associated activation antigen CD30 (3). 
Analysis of IgH and TCR fl locus confirmed our assump- 
tion that HD-MyZ cells lack lymphoid commitment. To our 
knowledge HD-MyZ is the only HD-derived cell line that 
is devoid oflg or TCR rearrangement. Little is known about 
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Table 4. Secretion fCytokines by HD-MyZ 
l hM lhPMA 40hM 40hPMA 
pg/ml 
IL-I~ 8 13 15 40 
IL-6 45 70 150 670 
IL-8 350 400 2,800 5,950 
106 cells/ml were incubated with culture medium in the presence or ab- 
sence of 10 ng/ml PMA. After the indicated incubation period, cells were 
pelleted, cell-free supernatants were collected, and cytokine concentra- 
tion was measured by ELISA. 
the involvement ofspecific oncogenes in the pathogenesis of 
HD. Studies on oncogene expression i different HD-derived 
cell lines revealed a heterogeneous pattern. Frequently expressed 
proto-oncogenes were c-myc, c-myb, c-raf, and N-ras (57). 
In our cell line specific transcripts for c-myc, c-myb, bcl-1, 
N-ras, and p53 tumor suppressor gene were detected. 
Since HD-MyZ cells showed phenotypical characteristics 
of myelomonocytoid differentiation (CD13, CD68, MHC 
class II), we were interested in studying the expression of 
a recently described intermediate filament-associated protein 
designated restin (44), which is found to be expressed athigh 
levels in H and KS cells and in in vitro cultivated human 
peripheral blood monocytes. Specific restin transcripts were 
detected in HD-MyZ cells. Expression of the c-f ms proto- 
Figure 7. Infiltration of spleen and 
metastatic lymph node by tumor cells. 
Tumors were dissected from SCID 
mice. Hematoxylin/eosin-stained sec- 
tions from metastatic lymph node 
tumor are shown (a), The tumor con- 
sists of large anaplastic multi- and 
mononucleated cells resembling KS or 
H cells. (b) Hematoxylin/eosin-stained 
spleen sections demonstrating i filtra- 
tion by tumor cells. 
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Figure 8. FCM | analysis of SCID mice de- 
rived human tumor cells. 10 6 tumor cells were 
used for FCM analysis with double immuno- 
fluorescence using PE-conjugated anti-HLA- 
DR mAb and FITC-labeled CD13 mAb or 
FITC-labeled IgG1 control mAb. For detection 
of human cells HLA-DR-positive cells were 
gated. Contour plots are depicted. Coexpres- 
sion of CD13 and HLA-DR is observed in all 
tumor calls. 
oncogene (CSF-1 receptor) could be induced in HD-MyZ 
cells by stimulation with PMA. c-f ms expression is correlated 
with monocytic differentiation (58). 
HD is clinically characterized byB symptoms, elevated acute 
phase reaction proteins, thrombocytosis, and histopathologo 
ically by sclerosis, eosinophilia, plasmocytosis, lymphocytic, 
and neutrophil reaction. These features might reflect he effects 
of tumor cell-derived cytokines. We therefore studied mRNA 
expression of various cytokines and cytokine receptors as well 
as the release of these cytokines into the supernatants. The 
pattern of cytokine production observed in HD-MyZ cells 
fits into the setting of monocytoid differentiation f this cell 
line and could explain some of the clinical and histopatho- 
logical features of HD. Autocrine production of growth factors 
has been suggested tobe involved in the pathogenesis of var- 
ious hematologic malignancies. Thus, TNF-o~ has been pro- 
posed as autocrine growth factor in hairy cell leukemia (59), 
IL-I~ in acute myeloid leukemia (60), and IL-6 in plasmocy- 
toma (61). Since some cytokines (IL-lo~, IL-1B, IL-6) were 
expressed constitutively in conjunction with their receptors, 
an autocrine growth model might also exist in HD-MyZ cells. 
Recently IL-6 secretion as well as IL-6 receptor expression 
were observed in several H cell lines (HDLM-2, KM-H2) 
as well as in HD tissue (62, 11). Neutralizing antibodies to 
recombinant IL-6, however, did not inhibit the growth of 
the cell lines tested (11). 
Using immunoperoxidase staining of tumor tissue, IL-1 
expression was observed in 20 patients with HD and in pa- 
tients with true histiocytic malignancies, whereas B or T cell 
lymphomas were devoid of IL-1 expression (63). The authors 
argued that this observation might provide further evidence 
for the relationship between RS cells and interdigitating retic- 
ulum cells. In the mean time IL-1 expression has been de- 
scribed in a variety of tumors. IL-1 has been discussed as an 
autocrine growth factor in acute myeloblastic leukemia (see 
above). Since HD-MyZ cells display monocytic features and 
simultaneously express IL-lcr IL-13, and IL-1 receptors, IL-1 
appears to be a likely candidate for an autocrine growth factor. 
Further studies using neutralizing antibodies or antisense oli- 
gonucleotides are warranted to clarify this model. 
Due to the fact that HD-MyZ constitutively secretes large 
amounts of IL-8 in the absence of IL-8 receptors (which, how- 
ever, can be induced by PMA treatment), IL-8 might have 
an important role as a paracrine rather than an autocrine 
cytokine. IL-8 might be responsible for inflammatory s mp- 
toms in patients with HD. 
One important criterion for defining an in vitro growing 
cell as malignant is the tumorigenic growth in nude or SCID 
mice. In addition SCID mice provide a useful in vivo model 
for studying human lymphoma growth and in vivo therapy 
strategies (64). The subcutaneous and intravenous inocula- 
tion of HD-MyZ cells into SCID mice led to the develop- 
ment of large tumor masses with infiltrative, destructive 
growth and to the evolution of extensive lymphadenopathy 
and splenomegaly. Histologically RS and H cells could be 
detected in these tissues. FCM analysis of human cells de- 
rived from these SCID mice tumors revealed the same pheno- 
type as the parental in vitro cell line. 
Due to the fact that the patient-derived cell line led to the 
development of disseminated tumors in SCID mice mimicking 
the patient's clinical picture concerning the localization of 
disease manifestations, we have reason to assume that this 
cell line indeed represents he disease-causing tumor cell. Taken 
together our data might suggest the following pathogenet- 
ical model: an activated myelomonocytic tumor cell with mor- 
phological characteristics of H or RS cells furnished with 
a broad repertoire of cytokines might cause the tissue reac- 
tion, as well as the biological heterogeneity observed in HD, 
and might sustain its growth in an autocrine fashion. The 
model using SCID mice might be of great value for under- 
standing the biological heterogeneity of HD and for testing 
novel therapeutic nterventions in vivo. 
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